[Clinical assessment of a new anesthetic system: the Temel Supra (II)].
To assess the clinical performance of a new anesthetic system developed to provide novel advantages in ventilating the anesthetized patient. The clinical performance of the Temel Supra was evaluated in 100 adult patients who were anesthetized and ventilated using the device. The patients were adequately oxygenated and ventilated; no adverse events were observed. An open circuit, low flow, or closed circuit could be chosen freely. Ventilation was fully monitored: among the variables measured were rebreathed volume; leaks while the patient was connected; consumption of oxygen, nitrous oxide and anesthetic agents; and cardiac output (noninvasively). Ventilation and gas exchange were satisfactory in all cases even though some patients developed considerable respiratory impedance. The monitoring of oxygen and other gases consumed and of carbon dioxide produced provided very valuable information about metabolism and pharmacokinetics. The noninvasive monitoring of cardiac output seems to us to be a useful feature for aiding hemodynamic control. The independence of the open and closed circuits means that expired gases do not pass through the canister when the open circuit is used, resulting in savings on soda lime for drying. During pressure-control ventilation, the system maintains a plateau to guarantee better distribution of inspired gases. Other important features are warnings, constant monitoring of leaks, the 100% efficacy of the circuit, and the low internal volume.